Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

B7-H4 Protein, Human, Recombinant (hFc & Avi), Biotinylated

(Synonyms: Vtcn1, V-set domain containing T cell activation inhibitor 1, V-set domai, T cell costimulatory molecule B7x, Protein B7S1, Immune costimulatory protein B7-H4, FLJ22418, B7XPRO1291, B7x, B7S1VCTN1, B7S1, B7H4T-cell costimulatory molecule B7x, B7-H4, B7h.5) Copy Product Info

Synonyms: Vtcn1, V-set domain containing T cell activation inhibitor 1, V-set domai, T cell costimulatory molecule B7x, Protein B7S1, Immune costimulatory protein B7-H4, FLJ22418, B7XPRO1291, B7x, B7S1VCTN1, B7S1, B7H4T-cell costimulatory molecule B7x, B7-H4, B7h.5

Catalog No. TMPJ-00176 Copy Product Info
B7 Homolog 4 (B7-H4) is glycosylated member of the B7 family of immune costimulatory proteins. Mature human B7-H4 consists of a 235 amino acid (aa) extracellular domain (ECD) with two Ig-like V-type domains, a 21 aa transmembrane segment, and a 2 aa cytoplasmic tail. It is widely expressed, including in kidney, liver, lung, pancreas, placenta, prostate, spleen, testis and thymus. B7-H4 negatively regulates T-cell-mediated immune response by inhibiting T-cell activation, proliferation, cytokine production and development of cytotoxicity. When expressed on the cell surface of tumor macrophages, plays an important role, together with regulatory T-cells (Treg), in the suppression of tumor-associated antigen-specific T-cell immunity. It also involved in promoting epithelial cell transformation.
Pack SizePriceUSA StockGlobal StockQuantity
5 μg$1297-10 days7-10 days
10 μg$2137-10 days7-10 days
20 μg$3557-10 days7-10 days
50 μg$6257-10 days7-10 days
100 μg$9637-10 days7-10 days
For In stock only · Estimated delivery: USA Stock (1-2 days) Global Stock (5-7 days)
Add to Cart
Add to Quotation
For research use only—not for human use. No sales to individuals. Use as intended only.
Questions
TargetMol
View More

Product Introduction

Bioactivity
Bioactivity
Immobilized Anti-Human B7-H4 mAb at 2μg/ml (100 μl/well) can bind Biotinylated Human B7-H4-Fc-Avi. The ED50 of Biotinylated Human B7-H4-Fc-Avi is 0.23 ng/ml. (Regularly tested)
Description
B7 Homolog 4 (B7-H4) is glycosylated member of the B7 family of immune costimulatory proteins. Mature human B7-H4 consists of a 235 amino acid (aa) extracellular domain (ECD) with two Ig-like V-type domains, a 21 aa transmembrane segment, and a 2 aa cytoplasmic tail. It is widely expressed, including in kidney, liver, lung, pancreas, placenta, prostate, spleen, testis and thymus. B7-H4 negatively regulates T-cell-mediated immune response by inhibiting T-cell activation, proliferation, cytokine production and development of cytotoxicity. When expressed on the cell surface of tumor macrophages, plays an important role, together with regulatory T-cells (Treg), in the suppression of tumor-associated antigen-specific T-cell immunity. It also involved in promoting epithelial cell transformation.
Species
Human
Expression System
HEK293 Cells
TagC-hFc-Avi
Accession NumberQ7Z7D3
Amino AcidPhe29-Ala258
ConstructionPhe29-Ala258
Protein Purity
Greater than 95% as determined by reducing SDS-PAGE. (QC verified)
Endotoxin< 0.1 ng/µg (1 EU/µg) as determined by LAL test.
FormulationLyophilized from a solution filtered through a 0.22 μm filter, containing PBS, pH 7.4.
ReconstitutionReconstitute the lyophilized protein in distilled water. The product concentration should not be less than 100 μg/ml. Before opening, centrifuge the tube to collect powder at the bottom. After adding the reconstitution buffer, avoid vortexing or pipetting for mixing.
Stability & StorageLyophilized powders can be stably stored for over 12 months, while liquid products can be stored for 6-12 months at -80°C. For reconstituted protein solutions, the solution can be stored at -20°C to -80°C for at least 3 months. Please avoid multiple freeze-thaw cycles and store products in aliquots.
ShippingIn general, lyophilized powders are shipped with blue ice, while solutions are shipped with dry ice.
SynonymsVtcn1, V-set domain containing T cell activation inhibitor 1, V-set domai, T cell costimulatory molecule B7x, Protein B7S1, Immune costimulatory protein B7-H4, FLJ22418, B7XPRO1291, B7x, B7S1VCTN1, B7S1, B7H4T-cell costimulatory molecule B7x, B7-H4, B7h.5
Research Background
B7 Homolog 4 (B7-H4) is glycosylated member of the B7 family of immune costimulatory proteins. Mature human B7-H4 consists of a 235 amino acid (aa) extracellular domain (ECD) with two Ig-like V-type domains, a 21 aa transmembrane segment, and a 2 aa cytoplasmic tail. It is widely expressed, including in kidney, liver, lung, pancreas, placenta, prostate, spleen, testis and thymus. B7-H4 negatively regulates T-cell-mediated immune response by inhibiting T-cell activation, proliferation, cytokine production and development of cytotoxicity. When expressed on the cell surface of tumor macrophages, plays an important role, together with regulatory T-cells (Treg), in the suppression of tumor-associated antigen-specific T-cell immunity. It also involved in promoting epithelial cell transformation.
Chemical Properties
Molecular Weight70-95 KDa (reducing condition)
Storage & Solubility Information
StorageLyophilized powder: -20~-80°C for 1 year | Solution: -80°C for 6 months

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: B7-H4 Protein, Human, Recombinant (hFc & Avi), Biotinylated chemical structure | B7-H4 Protein, Human, Recombinant (hFc & Avi), Biotinylated molecular weight